Front Page › Archive › Topic
6 stories on this topic.
***DISCLAIMER: This op-ed reflects the perspective of its contributor and does not necessarily represent the views of CT CannaTimes. We publish a range of voices to encourage open, honest discussion. ***
Dabbin’ Dad needs to explain its position.
That is the date the United States government was granted U.S. Patent No. 6,630,507 for cannabinoids, formally recognizing them as compounds with medical value, including antioxidant and neuroprotective properties with potential applications in conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke.
Hartford, CT — A provision in the amended version of House Bill 5350 creates a clear pathway for Social Equity cannabis businesses in Connecticut to be sold or transferred after a set period; while requiring a fixed state fee each time ownership changes.
The 2025 Medical Cannabis Caregiver Bill HB 5429 came closer than most people realize to breaking through and passing to the house.
O’Dea is pointing directly at cultivation concerns in the regulated market and acknowledging a reality policymakers rarely say out loud: the legacy market hasn’t gone anywhere, for a reason.
